MYO7A Polyclonal Antibody
Sizes: 60μL, 120μL, 200μL
Catalogue Numbers: E-AB-16626-60, E-AB-16626-120, E-AB-16626-200
Citations, Manuals and MSDS Available upon request.
Abbreviation: MYO7A
Target Synonym: Deafness autosomal dominant 11; Deafness autosomal recessive 2; DFNA11; DFNB 2; DFNB2; Myo7a; Myosin 7a; Myosin VIIA (Usher syndrome 1B (autosomal recessive; severe)); Myosin VIIa; Myosin; unconventional; family VII; member A; MYOVIIA; MYU7A; NSRD 2; NSRD2; Unconventional myosin VIIa; Ush 1B; Ush1b; Usher syndrome 1B
Research Areas: Cancer, Signal transduction
Conjugation: Unconjugated
Host: Rabbit
Species Reactivity: Human, Mouse
Application: IHC, ELISA
Isotype: IgG
Clonality: Polyclonal
UNIProt ID: Q13402
Background: This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants.
Concentration: 0.6 mg/mL
Immunogen: Synthetic peptide of human MYO7A
Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification Method: Affinity purification
Dilution: IHC 1:50-1:200
Storage: -20°C/One year. Avoid freeze / thaw cycles.
Shipping: Ice bag
Research Use Only